Drug Shortage Report for TEVA-IPRATROPIUM STERINEBS
| Report ID | 198292 |
| Drug Identification Number | 02216221 |
| Brand name | TEVA-IPRATROPIUM STERINEBS |
| Common or Proper name | TEVA-IPRATROPIUM STERINEBS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | IPRATROPIUM BROMIDE |
| Strength(s) | 250MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 10x2M |
| ATC code | R03BB |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-07-11 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-06-20 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2023-07-11 | English | Compare |